Mallinckrodt plc to Report Fourth Quarter Results on November 7, 2013
DUBLIN--(BUSINESS WIRE)--Oct. 7, 2013--
plc (NYSE: MNK) will report fourth quarter results on November 7, 2013.
The company will hold a conference call for investors beginning at
8:30am/U.S. Eastern Daylight Time. The call can be accessed in three
At the Mallinckrodt website: http://mallinckrodt.com/investor_relations.aspx
By telephone: For both “listen-only” participants and those who wish
to take part in the question-and-answer portion of the call, the
telephone dial-in number in the U.S. 877-703- 6107 For participants
outside the U.S., the dial-in number is 857-244-7306. The access code
for all callers is 20619575
Through an audio replay: A replay of the call will be available
beginning at 12:30pm/U.S. Eastern Daylight Time on November 7, 2013,
and ending at 12:59pm/U.S. Eastern Daylight Time on November 14, 2013.
The dial-in number for U.S. participants is 888-286-8010. For
participants outside the U.S., the replay dial-in number is 617-
801-6888. The replay access code for all callers is 67136812.
Mallinckrodt is a leading global specialty pharmaceuticals business that
develops, manufactures, markets and distributes specialty pharmaceutical
products and medical imaging agents. The company’s Specialty
Pharmaceuticals segment includes branded and generic drugs, and the
Global Medical Imaging segment includes contrast media and nuclear
imaging agents. Mallinckrodt has approximately 5,500 employees worldwide
with sales in roughly 70 countries. The company’s 2012 revenue totaled
$2.1 billion. To learn more about Mallinckrodt, visit www.mallinckrodt.com.
Source: Mallinckrodt plc
John Moten, 314-654-6650
Manager, Media Relations
Senior Vice President, Communications